Related references
Note: Only part of the references are listed.The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3
Annick Seithel et al.
DRUG METABOLISM AND DISPOSITION (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs
Sachiko Mita et al.
DRUG METABOLISM AND DISPOSITION (2006)
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
Ilaria Badagnani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Tubular transporters and clearance of adefovir
Aude Servais et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters
Supratim Choudhuri et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Transporters as a determinant of drug clearance and tissue distribution
Y Shitara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Organic anion transporter family: Current knowledge
Naohiko Anzai et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Polymorphisms and linkage disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects
Masayuki Tsujimoto et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
DL Bourdet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters
H Tahara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans
M Shimizu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Cyclosporine markedly raises the plasma concentrations of repaglinide
LI Kajosaari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats
T Deguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters
G Conseil et al.
PHARMACOGENETICS AND GENOMICS (2005)
Transporters and their impact on drug disposition
PM Beringer et al.
ANNALS OF PHARMACOTHERAPY (2005)
Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats
H Wong et al.
TOXICOLOGICAL SCIENCES (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2) - Implications for altered drug disposition and central nervous system drug entry
W Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat
A Treiber et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The SLC13 gene family of sodium sulphate/carboxylate cotransporters
D Markovich et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles:: Potential role for breast cancer resistance protein in clinical drug-drug interactions
P Breedveld et al.
CANCER RESEARCH (2004)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein
JS Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)
H Motohashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin:: Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
WH He et al.
NATURE (2004)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
MD Troutman et al.
PHARMACEUTICAL RESEARCH (2003)
Functional analysis of tight junctions
K Matter et al.
METHODS (2003)
Gemfibrozil greatly increases plasma concentrations of cerivastatin
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
KMM Doan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs
MT Huisman et al.
AIDS (2002)
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
DS Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice
DH Sweet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3
M Hayer-Zillgen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization
WM Barendt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interaction of human organic anion transporters with various cephalosporin antibiotics
M Takeda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion - Correlation of in vivo and in vitro studies
G Hill et al.
DRUG METABOLISM AND DISPOSITION (2002)
Isolation of a family of organic anion transporters from human liver and kidney
W Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
